Hormone therapy use may lead to fewer mood disturbances during the menopause transition

Mood disturbances—depressed mood, irritability, anxiousness and intelligence exhaustion—are communal during the menopause transition, affecting up to 68% of women. Although hormone therapy (HT) is FDA-approved for blistery flashes and genitourinary symptoms, its relation successful managing temper symptoms is little understood.